192 related articles for article (PubMed ID: 27001049)
1. Computational modeling approaches to the dynamics of oncolytic viruses.
Wodarz D
Wiley Interdiscip Rev Syst Biol Med; 2016 May; 8(3):242-52. PubMed ID: 27001049
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling approaches to studying the dynamics of oncolytic viruses.
Wodarz D
Math Biosci Eng; 2013 Jun; 10(3):939-57. PubMed ID: 23906157
[TBL] [Abstract][Full Text] [Related]
3. ODE models for oncolytic virus dynamics.
Komarova NL; Wodarz D
J Theor Biol; 2010 Apr; 263(4):530-43. PubMed ID: 20085772
[TBL] [Abstract][Full Text] [Related]
4. Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.
Wodarz D; Komarova N
PLoS One; 2009; 4(1):e4271. PubMed ID: 19180240
[TBL] [Abstract][Full Text] [Related]
5. Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches.
Wodarz D; Hofacre A; Lau JW; Sun Z; Fan H; Komarova NL
PLoS Comput Biol; 2012; 8(6):e1002547. PubMed ID: 22719239
[TBL] [Abstract][Full Text] [Related]
6. Multiscale model for the effects of adaptive immunity suppression on the viral therapy of cancer.
Paiva LR; Silva HS; Ferreira SC; Martins ML
Phys Biol; 2013 Apr; 10(2):025005. PubMed ID: 23492870
[TBL] [Abstract][Full Text] [Related]
7. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer.
Bell JC; McFadden G
Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227
[No Abstract] [Full Text] [Related]
8. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
9. In silico evolutionary dynamics of tumour virotherapy.
Reis CL; Pacheco JM; Ennis MK; Dingli D
Integr Biol (Camb); 2010 Jan; 2(1):41-5. PubMed ID: 20473411
[TBL] [Abstract][Full Text] [Related]
10. Multiscale moving boundary modelling of cancer interactions with a fusogenic oncolytic virus: The impact of syncytia dynamics.
Alzahrani T; Eftimie R; Trucu D
Math Biosci; 2020 May; 323():108296. PubMed ID: 31887267
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of oncolytic measles virus: promises and challenges.
Galanis E
Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
[TBL] [Abstract][Full Text] [Related]
12. Evolution of oncolytic viruses: novel strategies for cancer treatment.
Atherton MJ; Lichty BD
Immunotherapy; 2013 Nov; 5(11):1191-206. PubMed ID: 24188674
[TBL] [Abstract][Full Text] [Related]
13. Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor.
Su Y; Jia C; Chen Y
Biomed Res Int; 2016; 2016():5621313. PubMed ID: 28097139
[TBL] [Abstract][Full Text] [Related]
14. Questing for an optimal, universal viral agent for oncolytic virotherapy.
Paiva LR; Martins ML; Ferreira SC
Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
[TBL] [Abstract][Full Text] [Related]
15. Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection.
Alvarez-Breckenridge CA; Choi BD; Suryadevara CM; Chiocca EA
Curr Opin Virol; 2015 Aug; 13():25-32. PubMed ID: 25846988
[TBL] [Abstract][Full Text] [Related]
16. From virotherapy to oncolytic immunotherapy: where are we now?
Coffin RS
Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic viruses from the perspective of the immune system.
Alemany R; Cascallo M
Future Microbiol; 2009 Jun; 4(5):527-36. PubMed ID: 19492964
[TBL] [Abstract][Full Text] [Related]
18. Control exponential growth of tumor cells with slow spread of oncolytic virus.
Si W; Zhang W
J Theor Biol; 2015 Feb; 367():111-129. PubMed ID: 25435412
[TBL] [Abstract][Full Text] [Related]
19. The replicability of oncolytic virus: defining conditions in tumor virotherapy.
Tian JP
Math Biosci Eng; 2011 Jul; 8(3):841-60. PubMed ID: 21675814
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic Immunotherapy for Treatment of Cancer.
Tsun A; Miao XN; Wang CM; Yu DC
Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
